Search results
Results from the WOW.Com Content Network
[1] [5] [6] Some consider that the abnormalities need to be shown to be reversible. [4] [5] If lumbar puncture is performed this may show increased protein levels but no white blood cells. [1] [3] [4] Computed tomography scanning may be performed in the first instance; this may show low density white matter areas in the posterior lobes. [4]
Reversible posterior leukoencephalopathy syndrome; Megalencephalic leukoencephalopathy with subcortical cysts. It can also refer to gene MLC1 or Megalencephalic leukoencephalopathy with subcortical cysts 1, a human gene related to the former disease. Hypertensive leukoencephalopathy; The classification of leukoencephalopathies is a matter of ...
Posterior reversible encephalopathy syndrome has a similar presentation, and is found in 10–38% of RCVS patients. [1] RCVS is diagnosed by detecting diffuse reversible cerebral vasoconstriction. [1] Catheter angiography is ideal, but computed tomography angiography and magnetic resonance angiography can identify about 70% of cases. [1]
In hematology, plasma cell dyscrasias (also termed plasma cell disorders and plasma cell proliferative diseases) are a spectrum of progressively more severe monoclonal gammopathies in which a clone or multiple clones of pre-malignant or malignant plasma cells (sometimes in association with lymphoplasmacytoid cells or B lymphocytes) over-produce and secrete into the blood stream a myeloma ...
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal viral disease characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal).
Complications can include seizures, posterior reversible encephalopathy syndrome, and bleeding in the back of the eye. [1] [3] In hypertensive encephalopathy, generally the blood pressure is greater than 200/130 mmHg. [1] Occasionally it can occur at a BP as low as 160/100 mmHg. [4]
Mixed-phenotype acute leukemia (MPAL) is a group of blood cancers which have combined features of myeloid and lymphoid cancers. It is a rare disease, constituting about 2–5% of all leukemia cases. [1] It mostly involve myeloid with either of T lymphocyte or B lymphocyte progenitors, but in rare cases all the three cell lineages. [2]
B-cell prolymphocytic leukemia, referred to as B-PLL, is a rare blood cancer. It is a more aggressive, but still treatable, form of leukemia . Specifically, B-PLL is a prolymphocytic leukemia (PLL) that affects prolymphocytes – immature forms of B-lymphocytes and T-lymphocytes – in the peripheral blood, bone marrow, and spleen.